Currently, mesothelioma treatment, there is nobody that has been proven to be more effective. Surgery, radiation, chemotherapy, immunotherapy, and multimodality therapy treatments are all used to using. The prognosis of mesothelioma in the early phase of treatment is affected. Mesotheliomas of the previous stages of the investigation, which certainly have better prognoses. Solution, but is very rare. The patient's age, health status, and tumor of each patient's prognosis Histological contribution to the sub.
Surgery itself has been proven the most effective treatment for mesothelioma. Within the lining of the chest cavity that consists of putting Pleurectomy or decortication. The most common surgery for mesothelioma treatment to work. These are not simple and the purpose of removing the tumor with visible relief of the total gross is intended for patients with early stage disease. Otherwise extrapleural pneumonectomy (EPP) is the removal of the diseased lung, ipsilateral hemidiaphragm, and ipsilateral pericardium and olapadaravu inside the chest, and sometimes more advanced stages of mesothelioma are used on patients who may be cleared for surgery. Surgery is the only treatment modality, with an average survival time of 11.7 months for patients with mesothelioma was found in only.
Radio or radiation after surgery may also be used to consolidate the mesothelioma patients are placed. Radiation from the patient's chest drain insertion sites of the whole hemi-diaphragm and directed. In general, radiation is given concurrently with chemotherapy. The fundamental radiation and chemotherapy for patients who have undergone surgery after more than 5 years of this method was shown to extend the life of the patient. This is a big improvement in surgery, having received an average of 11.7 months.
Radio is also tumor growth, and or edema caused by obstruction of the lymph and blood vessels from the tumor's palliative therapy is used to relieve pain symptoms.
Chemotherapy has been proven to improve survival in some randomized controlled trials of patients. This is the only proven method of treatment is known as mesothelioma. As a result of cisplatin and pemetrexed therapy in patients with an average of approximately 13.3 months has been shown to increase survival time. In comparison, the average survival time of 10 months for patients who previously received cisplatin. Oral folate 500mcg daily and the body B 12, 1000 McG has a complement of each 9 weeks, most notably nausea, vomiting, stomatitis and diarrhea are less common side effects are shown.
For the treatment of malignant mesothelioma trials involving immunotherapy have been promised. Interferon in the treatment of malignant pleural mesothelioma - a number of experiments using an alpha of the patient population of more than 20% of the minimum of side effects has been shown to reduce tumor burden was 50%.
Multimodality therapy including surgery, adjuvant radiotherapy and chemotherapy is basically dominated by the most effective in dealing with malignant mesothelioma have been made to prove that. A number of experiments to predict the favorable factors for survival in patients 14 and 3 years at the time of the expansion of the currency.